August 15, 2023
VIA EDGAR TRANSMISSION
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Attention: Jimmy McNamara
Re:
Registration Statement on Form S-3
Registration No. 333-273822
Dear Mr. McNamara:
In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby
request acceleration of
the effective date of the Registration Statement on Form S-3 (File
No. 333-273822)
(the “Registration
Statement”) of Vaxxinity
,
Inc. We respectfully request
that the Registration Statement be declared effective as
of 4:00 P.M.
Eastern Time on August 18, 2023, or as soon
as practicable thereafter, or at such other time as our
legal counsel, Davis Polk & Wardwell
LLP,
may request by a telephone call to the staff of the U.S. Securities
Once the Registration Statement has been declared effective, please
orally confirm that event with our counsel,
Davis Polk & Wardwell
LLP,
by calling Yasin
Keshvargar at (212)
450-4839.
By:
/s/ Mei Mei Hu
Title:
Chief Executive Officer